Kali Therapeutics Wins FDA Clearance for KT501 IND
San Mateo, California, USA, September 3, 2026 Kali Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
San Mateo, California, USA, September 3, 2026 Kali Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...
Tokyo, Japan and Cambridge, Massachusetts, USA, September 3, 2026 Eisai Co., Ltd. and Biogen Inc. announced that China’s National...
ST. LOUIS, July 29, 2026 C2N Diagnostics, LLC announced that researchers in the United Kingdom are integrating its PrecivityAD2®...
